HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nanoceutical’s Absorption Studies Don’t Pick Up Disease Claims In NAD Review

Executive Summary

National Advertising Division, on challenge by Council for Responsible Nutrition, recommends Nanoceutical Solutions discontinue efficacy and establishment claims for Nano Glutathione.

You may also be interested in...



OTC Nasal Antiseptic NanoBio Protect ‘Lethal’ In COVID-19 In Vitro Tests, Amazon Launch Soon

BlueWillow Biologics points to recent in vitro tests it conducted with Public Health England showing NanoBio Protect killed COVID-19 as additional support for using nasal antiseptics to help prevent infections from the novel coronavirus. The firm also will soon offer sales of NanoBio Protect on Amazon.

Sales Grow Across C&D's Products And Regions, But Increasing Supply Costs Stunt Income

Raw material supplies slowed during January-March period by catastrophic freeze in Texas and shortage of shipping containers partly due to Suez Canal blockage. "We're absorbing $90 million of incremental costs for the full year,” says CFO Ronald Dierker.

Trade Groups Push US FDA To Close Window On Loosened OTC Sanitizer Production Standards

A day after FDA posted Scentsational’s recall announcement due to presence of benzene and acetaldehyde as well as methanol, American Cleaning Institute and Consumer Healthcare Products Association submit a letter urging FDA to restore order to OTC alcohol-based sanitizer market.

Topics

UsernamePublicRestriction

Register

RS150960

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel